Clinical perspectives: Practical insights from clinical experience with cabazitaxel in Australia-Reference-Cited by-同舟云学术

Clinical perspectives: Practical insights from clinical experience with cabazitaxel in Australia

Published:2015-04-09 Issue:3 Volume:11 Page:199-207
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Parente Phillip¹²,Gurney Howard³,Ng Siobhan⁴,Bahre Martina⁴

Affiliation:

1. Medical Oncology; Box Hill Hospital; Box Hill Australia

2. Faculty of Medicine; Monash University; Melbourne Victoria Australia

3. Clinical Research; Medical Oncology; Westmead Hospital; Sydney New South Wales Australia

4. Clinical Oncology; St John of God Private Hospital; Bendat Family Comprehensive Cancer Centre; Subiaco Western Australia Australia

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12343/fullpdf

Reference31 articles.

1. Active surveillance for prostate cancer: a review;Klotz;Curr Urol Rep,2010

2. Australian Institute of Health and Welfare Cancer incidence projections: Australia, 2011 to 2020 2012

3. ANZUP Cancer Trials Group Limited ANZUP Prostate Cancer Trials: Living Well with Prostate Cancer http://www.anzup.org.au/content.aspx?page=trials-prostate

4. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

5. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;Bono;Lancet,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Science and art of anticancer drug dosing: nine steps to personalised therapy;Internal Medicine Journal;2020-08

2. Continuing cabazitaxel beyond 10 cycles for metastatic castrate-resistant prostate cancer: is there a benefit?;European Journal of Hospital Pharmacy;2019-06-14

3. Dose modifications in adjuvant chemotherapy for solid organ malignancies: A systematic review of clinical trials;Asia-Pacific Journal of Clinical Oncology;2018-03-02

4. Cabazitaxel in patients with metastatic castration-resistant prostate cancer: safety and quality of life data from the Australian early access program;Asia-Pacific Journal of Clinical Oncology;2017-05-10

5. Cabazitaxel;Reactions Weekly;2016-12